Moleculin Biotech, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $16.9M
Liabilities Breakdown FY2024
Total Liabilities: $5.7M
Asset Breakdown
Total Assets: $16.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.3M | 25.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $159.0K | 0.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $12.5M | 73.8% |
Liabilities Breakdown
Total Liabilities: $5.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.0M | 35.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.7M | 64.5% |